Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1998-12-31
pubmed:abstractText
The association of maternal and perinatal factors with mother-infant transmission of HIV-1 was examined in a prospective multicenter cohort of singleton live births to 508 HIV-1-infected women with children of known HIV-1 infection status (91 [18%] HIV-1-infected, 417 [82%] uninfected). From multivariate logistic regression, independent predictors of HIV-1 transmission included maternal CD4 percentage (CD4%) (odds ratio [OR] per 10% increase in CD4% = 0.70; p = .003), ruptured membranes <24 hours (OR = 3.15; p = .02), and maternal bleeding (OR = 2.90; p = .03), whereas maternal zidovudine (ZDV) use was marginally associated (OR = 0.60; p = .08). The associations of maternal urinary cytomegalovirus (CMV) shedding, oropharyngeal Epstein-Barr virus (EBV) shedding, and serology profiles during pregnancy with HIV-1 transmission were examined in the subset of mothers in whom the CMV and EBV measurements were available. Maternal EBV seropositivity, CMV shedding, and CMV seropositivity were 100% (279 of 279), 7% (16 of 229), and 92% (270 of 274), respectively. These rates did not differ between transmitting and nontransmitting mothers. In univariate analyses, maternal EBV shedding was higher among transmitting than nontransmitting mothers (40 of 49 [82%] compared with 154 of 226 [68%]; p = .06) and was independently associated with transmission in multivariate logistic analyses adjusting for CD4%, ruptured membranes, and ZDV use, with an OR of 2.45 (95% confidence interval (CI), 1.03-5.84; p = .04). This permits the conclusion that EBV shedding is associated with maternal-infant HIV-1 transmission, independent of CD4%.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1077-9450
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
19
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
462-70
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:9859959-Anti-HIV Agents, pubmed-meshheading:9859959-CD4 Lymphocyte Count, pubmed-meshheading:9859959-CD4-CD8 Ratio, pubmed-meshheading:9859959-Cohort Studies, pubmed-meshheading:9859959-Cytomegalovirus, pubmed-meshheading:9859959-Female, pubmed-meshheading:9859959-Gestational Age, pubmed-meshheading:9859959-HIV Infections, pubmed-meshheading:9859959-HIV-1, pubmed-meshheading:9859959-Herpesviridae Infections, pubmed-meshheading:9859959-Herpesvirus 4, Human, pubmed-meshheading:9859959-Humans, pubmed-meshheading:9859959-Infant, Newborn, pubmed-meshheading:9859959-Infectious Disease Transmission, Vertical, pubmed-meshheading:9859959-Male, pubmed-meshheading:9859959-Oropharynx, pubmed-meshheading:9859959-Pregnancy, pubmed-meshheading:9859959-Pregnancy Complications, Infectious, pubmed-meshheading:9859959-Prospective Studies, pubmed-meshheading:9859959-Risk Factors, pubmed-meshheading:9859959-Urine, pubmed-meshheading:9859959-Uterine Hemorrhage, pubmed-meshheading:9859959-Virus Shedding, pubmed-meshheading:9859959-Zidovudine
pubmed:year
1998
pubmed:articleTitle
Maternal and perinatal factors related to maternal-infant transmission of HIV-1 in the P2C2 HIV study: the role of EBV shedding. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV-1 Infection (P2C2 HIV) Study Group.
pubmed:affiliation
Department of Pediatrics, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Multicenter Study